ACRS Aclaris Therapeutics, Inc.

Fundamentals / CIK 0001557746 / USD

Aclaris Therapeutics, Inc. reported $6.40M in revenue and a net loss of $79.63M for the trailing twelve months ended September 30, 2026 (down 55.1% year over year), with a 79.2% gross margin and a -1414.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACRS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$47.84M$23.92M$0-$153.5MFY 2016 Net Income: -$48.08M2016FY 2017 Revenue: $1.68MFY 2017 Net Income: -$68.52M2017FY 2018 Revenue: $6.15MFY 2018 Net Income: -$132.7M2018FY 2019 Revenue: $4.23MFY 2019 Net Income: -$161.4M2019FY 2020 Revenue: $6.48MFY 2020 Net Income: -$51.02M2020FY 2021 Revenue: $6.76MFY 2021 Net Income: -$90.86M2021FY 2022 Revenue: $29.75MFY 2022 Net Income: -$86.91M2022FY 2023 Revenue: $31.25MFY 2023 Net Income: -$88.48M2023FY 2024 Revenue: $18.72MFY 2024 Net Income: -$132.1M2024FY 2025 Revenue: $7.83MFY 2025 Net Income: -$64.92M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $7.83M $18.72M $31.25M $29.75M $6.76M $6.48M $4.23M $6.15M $1.68M --
Cost of Revenue $2.09M $2.79M $3.42M $4.02M $4.71M $5.13M $4.05M $4.33M $1.21M --
Gross Profit $5.74M $15.93M $27.83M $25.73M $2.05M $1.35M $172K $3.24M $476K --
Research & Development $52.65M $33.59M $98.38M $77.81M $43.81M $29.34M $64.17M $60.84M $35.80M $33.48M
Selling, General & Admin -- -- -- -- -- -- $28.50M $25.93M $19.03M $15.09M
Total Operating Expenses -- -- -- -- -- -- -- $138.7M $72.90M $48.57M
Operating Income -$76.38M -$141.9M -$97.36M -$89.85M -$89.72M -$50.91M -$111.1M -$84.78M -$54.36M -$48.57M
EBITDA -$75.92M -$141.1M -$96.49M -$89.06M -$88.80M -$49.59M -$104.6M -$82.90M -$53.96M -$48.45M
Interest Income $7.64M $7.95M $8.51M -- -- -- -- -- -- --
Income Before Tax -$64.92M -$132.1M -$88.85M -$86.91M -$90.86M -$51.34M -$113.5M -$82.10M -$70.35M -$48.08M
Income Tax Expense -- -- -$367K -- -- -$182K -- -- -$1.83M --
Net Income -$64.92M -$132.1M -$88.48M -$86.91M -$90.86M -$51.02M -$161.4M -$132.7M -$68.52M -$48.08M
Basic EPS -$0.53 -$1.71 -$1.27 -$1.33 -$1.60 -$1.20 -$3.90 -$4.03 -$2.44 -$2.25
Diluted EPS -$0.53 -$1.71 -$1.27 -$1.33 -$1.60 -$1.20 -$3.90 -$4.03 -$2.44 -$2.25
Basic Shares Outstanding 122.6M 77.3M 69.8M 65.2M 56.7M 42.5M 41.3M 32.9M 28.1M 21.4M
Diluted Shares Outstanding 122.6M 77.3M 69.8M 65.2M 56.7M 42.5M 41.3M 32.9M 28.1M 21.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.48M $1.63M $2.00M $1.29M $3.30M $1.78M $1.46M $9.21M
Cost of Revenue $189K $218K $395K $532K $538K $515K $506K $705K
Gross Profit $1.29M $1.41M $1.60M $763K $2.76M $1.26M $949K $8.51M
Research & Development $16.07M $18.07M $15.66M $16.58M $13.03M $11.45M $11.58M $9.03M
Operating Income -$21.34M -$24.24M -$22.19M -$22.73M -$17.15M -$18.41M -$18.08M -$99.67M
EBITDA -$21.24M -$24.13M -$22.09M -$22.63M -$17.04M -$18.29M -$17.96M -$99.53M
Interest Income $1.85M $1.76M $1.51M $1.63M $1.82M $2.02M $2.17M $2.10M
Income Before Tax -- -- -- -$19.80M -$14.61M -$15.43M -$15.09M -$96.55M
Net Income -$18.51M -$21.50M -$19.82M -$19.80M -$14.61M -$15.43M -$15.09M -$96.55M
Basic EPS -$0.12 -$0.15 -$0.15 -- -$0.12 -$0.13 -$0.12 --
Diluted EPS -$0.12 -$0.15 -$0.15 -- -$0.12 -$0.13 -$0.12 --
Basic Shares Outstanding 149.4M 142.7M 128.8M -- 122.6M 122.6M 122.4M --
Diluted Shares Outstanding 149.4M 142.7M 128.8M -- 122.6M 122.6M 122.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $19.96M $24.57M $39.88M $45.28M $27.35M $22.06M $34.19M -- $20.20M $30.17M
Short-Term Investments $70.79M $89.02M $79.23M $172.3M $164.1M $32.07M $39.08M $111.0M $173.7M $107.1M
Cash & Short-Term Investments $151.4M $203.9M $181.9M $229.8M $225.7M $54.10M $75.02M $168.0M $208.9M $174.1M
Accounts Receivable, Net -- $318K $298K $484K $623K $772K $704K $563K $481K --
Inventory -- -- -- -- -- -- $0 $791K $0 --
Total Current Assets $96.32M $126.0M $128.9M $231.6M $205.0M $57.49M $83.80M $179.5M $200.2M $138.6M
Property, Plant & Equipment, Net $761K $1.01M $1.62M $1.10M $1.33M $1.65M $2.47M $2.29M $2.16M $481K
Goodwill -- -- -- -- -- -- -- $18.50M $18.50M --
Intangible Assets -- -- $269K $6.97M $7.05M $7.12M $7.20M $7.27M $7.35M --
Long-Term Investments $60.61M $90.30M $62.77M $12.24M $34.24M -- -- -- $15.00M $36.91M
Other Non-Current Assets $2.77M $3.07M $4.16M $2.73M $3.55M $4.51M $4.83M $332K $279K $136K
Total Non-Current Assets $64.14M $94.38M $68.55M $23.05M $46.18M $13.29M $14.49M $96.07M $43.29M $37.53M
Total Assets $160.5M $220.3M $197.4M $254.6M $251.2M $70.78M $98.30M $275.6M $243.5M $176.1M
Accounts Payable $13.16M $4.69M $8.88M $10.35M $9.98M $5.25M $9.92M $11.68M $7.82M $2.85M
Deferred Revenue (Current) $3.94M $3.89M -- -- -- -- -- -- -- --
Other Current Liabilities $2.75M $2.68M $2.63M -- $693K $603K $637K $142K -- --
Total Current Liabilities $28.64M $31.60M $30.95M $21.94M $22.93M $14.87M $22.43M $27.34M $12.76M $6.22M
Long-Term Debt -- -- -- -- -- $10.65M -- $29.91M -- --
Deferred Revenue (Non-Current) $16.17M $20.04M -- -- -- -- -- -- -- --
Other Non-Current Liabilities $1.56M $4.44M $3.07M $1.57M $2.17M $3.18M $3.74M $476K $558K $372K
Total Non-Current Liabilities $28.73M $33.18M $9.27M $35.04M $30.94M $18.26M $5.95M $33.10M $5.49M $372K
Total Liabilities $57.38M $64.77M $40.23M $56.98M $53.87M $33.13M $28.39M $60.44M $18.25M $6.59M
Total Debt (incl. Leases) $2.12M $2.60M $3.50M $2.25M $2.84M $14.15M $4.18M $29.91M -- --
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K -- -- -- -- --
Retained Earnings -$967.8M -$902.9M -$770.8M -$682.3M -$595.4M -$504.5M -$453.5M -$292.2M -$159.4M -$90.91M
Accumulated Other Comp. Income $610K $97K -$106K -$897K -$224K -$94K -$66K -$69K -$246K -$269K
Total Stockholders' Equity $103.1M $155.6M $157.2M $197.6M $197.3M $37.65M $69.91M $215.1M $225.3M $169.5M
Total Equity $103.1M $155.6M $157.2M $197.6M $197.3M $37.65M $69.91M $215.1M $225.3M $169.5M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $20.39M $19.17M $28.66M $19.96M $25.26M $25.40M $30.36M $24.57M
Short-Term Investments $93.90M $72.39M $76.76M $70.79M $70.66M $74.40M $74.96M $89.02M
Cash & Short-Term Investments $204.6M $170.6M $190.8M $151.4M $167.2M $180.9M $190.5M $203.9M
Accounts Receivable, Net -- -- -- -- -- $194K $250K $318K
Total Current Assets $123.2M $97.77M $110.2M $96.32M $100.6M $104.2M $108.8M $126.0M
Property, Plant & Equipment, Net $624K $664K $750K $761K $811K $868K $942K $1.01M
Long-Term Investments $90.31M $79.06M $85.37M $60.61M $71.30M $81.08M $85.21M $90.30M
Other Non-Current Assets $1.99M $2.20M $2.37M $2.77M $2.83M $2.99M $3.15M $3.07M
Total Non-Current Assets $92.92M $81.93M $88.49M $64.14M $74.94M $84.94M $89.30M $94.38M
Total Assets $216.2M $179.7M $198.7M $160.5M $175.5M $189.1M $198.1M $220.3M
Accounts Payable $9.07M $15.52M $14.73M $13.16M $9.19M $8.80M $6.35M $4.69M
Deferred Revenue (Current) $3.97M $3.98M $3.97M $3.94M $3.92M $3.91M $3.89M $3.89M
Other Current Liabilities $2.81M $2.79M $2.77M $2.75M $2.73M $2.72M $2.70M $2.68M
Total Current Liabilities $24.22M $28.24M $27.37M $28.64M $25.63M $26.84M $21.51M $31.60M
Deferred Revenue (Non-Current) $13.33M $14.31M $15.29M $16.17M $17.49M $18.22M $19.21M $20.04M
Other Non-Current Liabilities $1.10M $1.26M $1.42M $1.56M $1.71M $1.85M $4.31M $4.44M
Total Non-Current Liabilities $25.14M $26.87M $27.70M $28.73M $29.80M $30.57M $32.51M $33.18M
Total Liabilities $49.36M $55.11M $55.07M $57.38M $55.43M $57.41M $54.03M $64.77M
Total Debt (incl. Leases) $1.71M $1.85M $1.99M $2.12M $2.24M $2.37M $2.48M $2.60M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$1.03B -$1.01B -$987.6M -$967.8M -$948.0M -$933.4M -$917.9M -$902.9M
Accumulated Other Comp. Income -$1.12M -$304K $22K $610K $597K $482K $434K $97K
Total Stockholders' Equity $166.8M $124.6M $143.6M $103.1M $120.1M $131.7M $144.1M $155.6M
Total Equity $166.8M $124.6M $143.6M $103.1M $120.1M $131.7M $144.1M $155.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$64.92M -$132.1M -$88.48M -$86.91M -$90.86M -$51.02M -$161.4M -$132.7M -$68.52M -$48.08M
Depreciation & Amortization $454K $807K $863K $797K $923K $1.32M $6.41M $1.88M $402K $120K
Stock-Based Compensation $12.38M $10.86M $20.54M $15.04M $14.06M $11.21M $16.18M $20.05M $14.43M $6.10M
Change in Receivables -- -$20K $186K $139K $149K $4.90M -$809K -$4.38M -- --
Change in Inventory -- -- -- -- -- -- $605K $102K -- --
Change in Payables $8.45M -$4.19M -$1.47M $368K $3.65M -$5.22M -$3.16M $6.96M $4.56M $1.81M
Operating Cash Flow -$47.11M -$20.07M -$78.33M -$67.57M -$52.13M -$38.63M -$96.44M -$100.8M -$54.66M -$34.60M
Capital Expenditure -$111K -$121K -$1.31M -$605K -$308K -$453K -$1.61M -$1.36M -$1.24M -$232K
Free Cash Flow -$47.22M -$20.20M -$79.63M -$68.17M -$52.44M -$39.09M -$98.06M -$102.2M -$55.90M -$34.84M
Acquisitions, Net -- -- -- -- -- -- -- -- -$9.65M --
Purchases of Investments -$39.73M -$120.0M -$135.7M -$164.8M -$235.2M -$47.71M -$137.4M -$161.6M -$197.3M -$148.8M
Investing Cash Flow $48.37M -$69.77M $46.22M $12.63M -$167.6M $6.39M $105.7M $9.37M -$55.69M -$61.90M
Common Stock Issued -- -- -- -- -- -- -- -- -- $98.16M
Financing Cash Flow -$5.86M $74.54M $26.71M $72.87M $225.1M $18.37M -$30.32M $128.3M $100.4M $116.8M
Net Change in Cash -$4.61M -$15.31M -$5.40M $17.93M $5.29M -$13.87M -$21.08M $36.82M -$9.97M $20.32M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$18.51M -$21.50M -$19.82M -$19.80M -$14.61M -$15.43M -$15.09M -$96.55M
Depreciation & Amortization $100K $107K $102K $102K $110K $114K $128K $143K
Stock-Based Compensation $3.02M $2.67M $3.20M $2.93M $2.86M $3.06M $3.54M $2.86M
Change in Receivables -- -- -- -- -- $56K $68K $25K
Change in Payables -$6.47M $842K $1.51M $3.96M $377K $2.44M $1.66M -$2.97M
Operating Cash Flow -$24.08M -$19.85M -$18.15M -$13.13M -$10.93M -$9.99M -$13.06M -$8.94M
Capital Expenditure -$13K -$58K -$13K -$24K -$23K -$21K -$43K $0
Free Cash Flow -$24.09M -$19.91M -$18.16M -$13.15M -$10.96M -$10.01M -$13.10M -$8.94M
Purchases of Investments -$53.20M -$8.93M -$51.67M -$4.61M -$5.20M -$19.93M -$10.00M --
Investing Cash Flow -$33.22M $10.26M -$30.93M $10.37M $13.83M $5.05M $19.12M -$88.72M
Financing Cash Flow $58.52M $91K $57.78M -$2.53M -$3.04M -$9.0K -$275K $74.58M
Net Change in Cash $1.23M -$9.49M $8.70M -$5.30M -$146K -$4.96M $5.79M -$23.08M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 73.3% 85.1% 89.0% 86.5% 30.3% 20.8% 4.1% 52.7% 28.3% --
Operating Margin -975.9% -758.2% -311.6% -302.0% -1327.1% -785.4% -2627.3% -1378.3% -3230.0% --
Net Profit Margin -829.6% -705.5% -283.1% -292.1% -1344.0% -787.0% -3817.2% -2158.0% -4071.5% --
Return on Equity (ROE) -63.0% -84.9% -56.3% -44.0% -46.0% -135.5% -230.8% -61.7% -30.4% -28.4%
Return on Assets (ROA) -40.5% -59.9% -44.8% -34.1% -36.2% -72.1% -164.1% -48.2% -28.1% -27.3%
Current Ratio 3.36x 3.99x 4.16x 10.55x 8.94x 3.87x 3.74x 6.56x 15.69x 22.27x
Quick Ratio 5.29x 6.46x 5.89x 10.50x 9.87x 3.69x 3.74x 6.54x 15.69x 27.98x
Debt to Equity 0.02x 0.02x 0.02x 0.01x 0.01x 0.38x 0.06x 0.14x -- --
Revenue Growth (YoY) -58.2% -40.1% +5.0% +340.1% +4.3% +53.3% -31.3% +265.5% -- --
Gross Profit Growth (YoY) -64.0% -42.8% +8.2% +1156.3% +51.8% +684.3% -94.7% +580.9% -- --
5Y Revenue / Share Growth -58.1% +136.8% +139.5% +661.8% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 79.2% 79.5% 76.3% 73.3% 85.6% 85.8% 86.0% 85.1%
Operating Margin -1414.0% -1050.2% -961.9% -975.9% -973.9% -873.4% -793.6% -758.1%
Net Profit Margin -1244.1% -921.5% -832.6% -829.6% -900.0% -802.0% -732.4% -705.4%
Return on Equity (ROE) -47.7% -60.8% -48.5% -63.0% -118.0% -102.2% -90.4% -84.9%
Return on Assets (ROA) -36.8% -42.1% -35.1% -40.5% -80.7% -71.2% -65.7% -59.9%
Current Ratio 5.09x 3.46x 4.03x 3.36x 3.92x 3.88x 5.06x 3.99x
Quick Ratio 8.45x 6.04x 6.97x 5.29x 6.52x 6.75x 8.87x 6.46x
Debt to Equity 0.01x 0.01x 0.01x 0.02x 0.02x 0.02x 0.02x 0.02x
Revenue Growth (YoY) -55.1% -8.3% +37.2% -85.9% -24.1% -35.8% -39.3% -47.6%
Gross Profit Growth (YoY) -53.2% +11.8% +68.7% -91.0% -25.2% -41.1% -40.3% -49.5%
Operating Cash Flow Growth (YoY) -- -- -- -- -149.7% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -149.8% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001557746) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:34 UTC · Open in terminal